CATALOGO DEI PRODOTTI DELLA RICERCA

BELLINATO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.277
NA - Nord America 2.581
AS - Asia 2.164
SA - Sud America 447
AF - Africa 147
OC - Oceania 46
Totale 8.662
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.495
RU - Federazione Russa 1.552
SG - Singapore 960
IT - Italia 519
CN - Cina 402
BR - Brasile 370
HK - Hong Kong 274
DE - Germania 226
GB - Regno Unito 197
IE - Irlanda 160
SE - Svezia 139
VN - Vietnam 127
FI - Finlandia 119
FR - Francia 111
KR - Corea 97
NL - Olanda 65
ID - Indonesia 62
TR - Turchia 49
IN - India 47
TG - Togo 47
ES - Italia 43
BJ - Benin 41
AU - Australia 40
CA - Canada 40
JP - Giappone 35
MX - Messico 35
PL - Polonia 25
AR - Argentina 24
AT - Austria 24
ZA - Sudafrica 22
EC - Ecuador 16
IR - Iran 16
CL - Cile 13
MY - Malesia 13
SA - Arabia Saudita 13
UA - Ucraina 12
BD - Bangladesh 11
PH - Filippine 10
CH - Svizzera 9
DK - Danimarca 8
HR - Croazia 8
BE - Belgio 7
CO - Colombia 7
UZ - Uzbekistan 7
EG - Egitto 6
IQ - Iraq 6
NG - Nigeria 6
PK - Pakistan 6
PT - Portogallo 6
RO - Romania 6
DZ - Algeria 5
GR - Grecia 5
IL - Israele 5
IS - Islanda 5
NZ - Nuova Zelanda 5
UY - Uruguay 5
BG - Bulgaria 4
HU - Ungheria 4
KE - Kenya 4
MA - Marocco 4
PY - Paraguay 4
VE - Venezuela 4
AL - Albania 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
GD - Grenada 3
GH - Ghana 3
NO - Norvegia 3
TN - Tunisia 3
TW - Taiwan 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
NP - Nepal 2
RS - Serbia 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NC - Nuova Caledonia 1
Totale 8.655
Salva come PNG Salva come JPEG
Città #
Dallas 796
Moscow 554
Singapore 371
Ashburn 276
Chandler 267
Hong Kong 261
Dublin 149
Munich 113
Beijing 90
Los Angeles 78
Helsinki 76
New York 70
Milan 60
London 59
Ho Chi Minh City 50
Jakarta 49
Verona 49
Lomé 47
Cotonou 41
Southend 39
Redondo Beach 37
Rome 35
Lawrence 34
Princeton 34
Buffalo 32
São Paulo 31
Hanoi 30
Houston 28
Naples 28
Seattle 28
Lappeenranta 26
Jacksonville 25
Sindelfingen 25
Wilmington 25
Washington 24
Amsterdam 23
Santa Clara 23
The Dalles 22
Tokyo 22
Warsaw 21
Bologna 20
Chicago 20
Nuremberg 19
Venice 19
Mexico City 18
Frankfurt am Main 17
Brooklyn 16
Chennai 16
Phoenix 16
Sydney 16
Atlanta 15
Council Bluffs 13
Kuala Lumpur 13
Madrid 13
Xi'an 13
Boston 12
Enfield 12
Guangzhou 12
Johannesburg 12
Rio de Janeiro 12
Tianjin 12
Turin 12
Belo Horizonte 11
Toronto 11
Brasília 10
Columbus 10
Istanbul 10
Montreal 10
Perth 10
Shanghai 10
Dongguan 9
Esslingen am Neckar 9
Mumbai 9
Vienna 9
Jinan 8
Mersin 8
Santiago 8
Stockholm 8
Copenhagen 7
Curitiba 7
Florence 7
Orem 7
San Jose 7
Tashkent 7
Turku 7
Vicenza 7
Ankara 6
Ann Arbor 6
Barcelona 6
Brussels 6
Da Nang 6
Denver 6
Downers Grove 6
Genoa 6
Goiânia 6
Jyväskylä 6
Kent 6
Las Vegas 6
Manchester 6
Pescara 6
Totale 4.666
Salva come PNG Salva come JPEG
Nome #
Il ruolo della vitamina D nella dermatite atopica 287
Real-World Effectiveness of Bimekizumab in Predominantly Difficult-to-Treat Patients with Psoriatic Arthritis Followed in a Combined Dermatology-Rheumatology Clinic: A 24-Week Multicenter Study 279
A systematic review of treatments for pityriasis lichenoides 276
Dietary supplements for lipedema 275
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study 247
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 144
Polymorphisms, diet and nutrigenomics 143
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 139
Impact of the COVID-19 pandemic on melanoma diagnosis 137
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. 135
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 131
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 129
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis 122
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 122
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 118
Amicrobial Pustulosis of the Folds: Report of Three New Cases 116
Adrenergic urticaria successfully treated with omalizumab 108
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis 108
Coexistence of scleromyxedema and Sneddon syndrome 105
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 102
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study 102
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease 102
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 100
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis 100
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 99
Clinical profile and co-infections of urethritis in males 97
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 96
Dermoscopic features of nevoid melanoma: a retrospective study 94
Price variability of TNF-α inhibitor biosimilars among European countries 93
Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma 91
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review 91
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 90
Pretibial Dystrophic Epidermolysis Bullosa Successfully Treated with Upadacitinib: A Case Report 90
The transition from mild to moderate-to-severe chronic plaque psoriasis 88
Clinical‐epidemiological aspects of the Monkeypox 2022 epidemic: a multicenter study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 86
Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination 84
Consensus on the place in therapy of TNF-a inhibitors in the treatment of patients with chronic plaque psoriasis 83
Primary nodular localized cutaneous amyloidosis of the scalp associated with systemic lupus erythematosus 83
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities 82
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series 80
Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome 80
Predictors of subsequent primary melanoma: a case-control study 77
Main nutritional deficiencies 77
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis 77
The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events 76
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines 76
Dietary supplements for the management of COVID-19 symptoms 75
Sezary syndrome with large cell transformation and T-follicular helper phenotype 74
BRAF-Mutated Melanoma Cell Lines Develop Distinct Molecular Signatures After Prolonged Exposure to AZ628 or Dabrafenib: Potential Benefits of the Antiretroviral Treatments Cabotegravir or Doravirine on BRAF-Inhibitor-Resistant Cells 73
Certolizumab pegol in severe hidradenitis suppurativa in pregnancy: A case report 72
Awareness of obesity among patients with psoriasis 72
Dupilumab for recalcitrant Kimura disease 72
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis 71
Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs 71
Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies 70
Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review 69
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies 69
Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics 68
Managing the Patient with Psoriasis and Metabolic Comorbidities 68
Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission. 68
In vitro cell culture of amniotic fluid keratinocytes on amniotic membrane: the ideal tissue for repairing skin ulcers 67
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review 67
Lamivudine, Doravirine, and Cabotegravir downregulate the expression of Human Endogenous Retroviruses (HERVs), inhibit cell growth, and reduce invasive capability in melanoma cell lines 66
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules 65
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study 64
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis 64
The Risk of COVID‐19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 64
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the “Save Your Skin” Screening Campaign 63
Optimization of long-range PCR protocol to prepare filaggrin exon 3 libraries for PacBio long-read sequencing 63
Upadacitinib in refractory cutaneous pseudolymphoma: A case report 63
Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevant responsibility issue for dermatologists 62
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience 61
Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis 61
Monkeypox virus infection: what dermatologist needs to know? 60
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV2 infection and vaccination 59
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach 59
Validating methods for testing natural molecules on molecular pathways of interest in silico and in vitro 57
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis 56
Is risankizumab as needed administration a good option for patients with plaque psoriasis? 56
Polyphenols and Lactobacillus reuteri in oral health 51
Generalized pustular psoriasis successfully treated with spesolimab: A case report 51
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment 48
Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis? 48
X-linked genodermatoses from diagnosis to tailored therapy 46
Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks 46
Omics sciences and precision medicine in melanoma 45
Scurvy as Presenting Sign of Anorexia Nervosa 45
Biosimilars for the Treatment of Moderate to Severe Chronic Plaque Psoriasis 45
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 44
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort 43
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis 43
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis 42
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study 42
Long-term follow-up of Zoon balanitis: a retrospective cohort study 41
Novel loss-of-function variants in filaggrin exon 3 in patients with severe atopic dermatitis 41
Psoriasis: talking points from recent clinical trials 40
Corymbose Syphilis 39
PsoBioVax: A multicentric Italian case–control study of the immunological response to anti‐SARS‐CoV‐2 vaccine among psoriatic patients under biological therapy 38
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 38
Super Responder Profle Under Bimekizumab Treatment in Moderate‐to‐Severe Psoriasis: A Short Term Real‐Life Observation—IL PSO (Italian Landscape Psoriasis) 36
Totale 8.598
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.763
article - articoli 34.763
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.526
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 15 14 10 1 4 4 13 4
2021/2022224 12 27 4 12 31 12 15 16 11 12 17 55
2022/20231.126 38 72 63 144 63 203 15 53 210 157 78 30
2023/2024940 59 64 97 102 82 166 67 57 16 44 108 78
2024/20252.473 119 104 125 379 118 145 227 112 376 192 167 409
2025/20263.898 423 480 684 883 1.428 0 0 0 0 0 0 0
Totale 8.797